In Human Erythroid Massive Amplification (HEMA) cultures, AB mononuclear cells (MNC) generate 1-log more erythroid cells (EBs) than the corresponding CD34 pos cells, suggesting that MNC may also contain CD34 neg HPC. To clarify the phenotype of AB HPC which generate EBs in these cultures, flow cytometric profiling for CD34/CD36 expression, followed by isolation and functional characterization (colony-forming-ability in semisolid-media and fold-increase in HEMA) were performed. neg CD36 neg cells generated EBs with fold-increases of ≈9,000, 100, 60 and 1, respectively, and maturation times (day with >10% CD36 high CD235a high cells) of 10-7 days. Pyrenocytes were generated only by CD34 neg /CD36 neg cells by day 15. These results confirm that the majority of HPC in AB express CD34 but identify additional CD34 neg populations with erythroid differentiation potential which, based on differences in fold-increase and maturation times, may represent a hierarchy of HPC present in AB.
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Introduction
Hematopoiesis is defined as the orderly sequence of events that replenishes the cellular elements of the blood on a daily basis [1] . Under steady-state conditions, the bone marrow provides the microenvironmental cues that allow hematopoietic stem cells to generate a hierarchy of cells (the hematopoietic progenitor cells, HPCs) progressively more restricted in their proliferation and lineage maturation potential [2] . In addition, bone marrow contains very rare precursor cells with the potential to generate hematopoietic stem cells [3] . Human stem cell precursors and stem cells are functionally defined by surrogate assays in animal models [4] , while HPCs with different proliferation/maturation potential are defined by semisolid cultures that model the hematopoietic process in vitro [5] . These functional in vitro assays provided the basis for the identification and prospective isolation of a hierarchy of different hematogenic populations present in bone marrow [6] . Based on number and lineage of the cells generated and of the time required for their generation, semisolid assays identify a series of HPCs: HPCs able to generate large colonies (>30,000 cells) comprising cells of multiple lineages (the colony-forming unit, granulocyticerythroid-megakaryocitic-monocytic, CFU-GEMM) by day 15-18, those which generate erythroid bursts (approximately 5,000 cells, burst-forming unit erythroid BFU-E) and granulomonocytic colonies (colony forming unit, granulomonocytic, CFU-GM) by day 12-15, and finally those which generate clusters (50-200 cells) composed only by erythroid (colony-forming unit, erythroid, CFU-E), granulocytic (CFU-G) or monocytic (CFU-M) cells by day 8 [5] .
CD34 is an antigen expressed by HPCs of all types whose expression is lost at the CFU-E level [5, 6] . CFU-GEMM express also CD38 but do not express the α subunit of 2 Stem Cells International the interleukin-3 (IL-3) receptor, which is acquired during the transition of these cells to BFU-E, CFU-GM, and CD45RA [7, 8] , which is specifically expressed by BFU-E [5, 6] . CD36 is an antibody that recognizes thrombospondin, the receptor for the malarial parasite whose expression is activated within a few hours of exposure to erythropoietin (EPO) [9] . Although it is conceivable that CD36 is expressed by erythroid cells of all types, how its expression is modulated during the transition from CFU-GEMM to CFU-E is not known. HPCs may egress from the bone marrow into the circulation [2] . However, since maturation alters the adhesion receptor profile of the cells and their affinity for the marrow niches, HPCs are released from the marrow with different efficiencies and their frequency in blood may not correspond to that of the marrow [10] . The majority of erythroid HPCs in the marrow are CFU-E, but the majority (>90%) of those in blood are BFU-E [11] .
The HPCs present in adult peripheral blood (AB) are discarded during the leukoreduction process used to prepare red blood cells for transfusion. Discarded AB HPCs are used in several liquid culture systems to generate great numbers of lineage-restricted precursors to study hematopoiesis [12, 13] . More recently, it has been realized that AB HPCs discarded in the buffy coat from a single donation cultured in the presence of dexamethasone (DXM) and estradiol (ES), and in addition to stem cell factor (SCF), IL-3 and EPO (human erythroid massive amplification, HEMA, culture) [14] may generate erythroblasts (EBs) in numbers sufficient for 3-50 transfusions [15] , paving the way for an important area of translational medicine: production of alternative transfusion products ex vivo. Although both AB mononuclear (MNC) and CD34 pos cells generate great numbers of EBs in HEMA culture, the total number of erythroid cells generated by CD34 pos cells is on average 1-log lower than that generated by MNC [13] . This observation has been ascribed to loss of HPCs with erythroid differentiation potential (erythroid precursor cells, EPC) during the CD34 selection procedure and/or to the existence of circulating CD34 neg EPC. The second hypothesis is supported by a recent report indicating that AB CD34 neg cells may differentiate into EBs under HEMA conditions generating more EBs than the corresponding CD34 pos cells [16] . The phenotype of the CD34 neg cells with erythroid potential present in AB buffy coats is not known. The aim of our study was to further clarify the phenotype of the HPCs/EPC present in AB MNC and to evaluate their contribution to the generation of EBs under HEMA conditions. Flow cytometric profiling for CD34 and CD36 expression of AB MNC followed by functional characterization (colony-forming ability in semisolid media and fold increase in HEMA) of the prospectively isolated populations was perfomed. The results presented indicate that CD34/CD36 profiling identifies a hierarchy of EPC in AB. 
Materials and Methods

Colony-Forming Assay.
The colony forming ability of unfractionated and sorted cells was evaluated in standard semisolid methylcellulose cultures (40%, Fluka Biochemika) stimulated with human SCF (10 ng/mL), IL-3 (10 ng/mL), granulocyte-macrophage colony-stimulating factor (GM-CSF, 10 ng/mL), granulocyte colony-stimulating factor (G-CSF, 100 ng/mL) and EPO (5 U/mL) [18] . The cultures were incubated at 37
• C in a fully humidified 5% pCO 2 atmosphere and scored after 14 days for the growth of hematopoietic colonies. CFU-GEMM-, BFU-E-, and CFU-GM-derived colonies were recognized according to standard morphological criteria [18, 19] .
Ex Vivo Expansion of Human EBs under HEMA Conditions. MNC (10 6 cells/mL) and prospectively isolated cells (5 × 10
4 cells/mL) were cultured under HEMA conditions, as described [14] . Briefly, the cultures contained Iscove's mod- pos and CD36 neg cells by magnetic bead isolation. The cells eluted from the beads were purified by sorting on the basis of lack of expression of CD14 and low level of CD36 expression (population C, purple). The CD14 neg CD36 high cells (population D, blue) were not isolated because expressed high levels of the megakaryocytic marker CD42a. Finally, the CD36 beads flow-through fraction was enriched for CD36 neg cells by sorting. These CD36 neg cells were also CD34 neg upon reanalyses (not shown). Whenever feasible, the prospectively isolated cells were reanalyzed for purity. Results are representative of those obtained in 3 independent purifications. iLL, USA) [15] , human SCF (50 ng/mL, Sigma-Aldrich), EPO (3 U/mL, Neorecormon, Auckland, New Zealand) and IL-3 (10 ng/mL, Biosource, San Jose, Calif, USA), DXM (10 −6 M) and ES (10 −6 M) (both from Sigma-Aldrich), Lglutamine (200 mM, Euroclone SpA, Siziano, Italy), antibiotics [penicillin (10,000 units/mL), streptomycin sulfate (10,000 μg/mL), fungizone (25 μg/mL), Lonza Group Ltd], and β-mercaptoethanol (10 −6 M). The cultures were kept for up to 10-15 days at 37
• C and 5% pCO 2 in a fully humidified incubator.
Cell Viability, Phenotypic Analysis and Sorting.
Cell numbers and viability were assessed by microscopic evaluation after trypan blue (Boston Bioproducts, Ashland, Mass, USA) staining. For flow cytometrical characterization, cells were suspended in Ca 2+/ Mg 2+ -free phosphate-buffered saline, supplemented with 1% BSA, 2 mmol/L ethylenediamine tetraacetate (EDTA), and 0.01% NaN3, stained with either allophycocyanin-(APC-) conjugated CD36 or phycoerythrin-(PE-) conjugated CD235a (antiglycophorin A), or appropriate isotype controls (all from Becton Dickinson Biosciences) and analyzed with the FACS Aria. Dead cells were excluded by SYTOX Blue (0.002 mM, Molecular Probes) staining. Forward and side scatter analyses of cells expressing the mature CD36 low CD235a high phenotype and of small size were used for the identification of pyrenocytes [20] .
Statistical Analysis.
Results are presented as mean (±SD) of those obtained in at least three experiments per data set. Mean (±SD) were calculated with the computer software Origin 5.0 for Windows (Microcal Software, Inc., Northampton, Mass, USA). (Figure 1(a) ). CD34 neg CD36 pos cells could in turn be divided into three populations: the majority of them expressed CD14 and was, therefore, represented by monocytes (monocytes are known to express CD36) [21] (Figure 1(b) ). By dot blot distribution and CD42a staining, the remaining could be divided into two additional populations: CD34 neg CD36 low (population C, ∼2%), which does not express CD42a, and CD34 neg CD36 high (population D, ∼1.0), which express high levels of CD42a (mean fluorescence intensity, MFI > 15, 000) (Figure 1(b) ).
Results
Antigenic Profiling of AB
Prospective Isolation of MNC Populations Based on CD34
and CD36 Expression. AB MNCs were purified on the basis of CD34 and CD36 expression by the combination of magnetic bead enrichment and cell sorting described in Figure 1 (Table 1) . Population A was >98% pure by reanalyses while the purity of population B was not determined due to low cell recovery.
Reanalyses for CD36 and CD14 expression of the flowthrough fraction of the CD34-coated magnetic beads revealed that a great number (∼78%) of CD36 pos cells expressed also CD14. This flow-through fraction was further divided into CD36-enriched and CD36-deprived fractions by CD36-magnetic bead isolation. The cells adsorbed to the beads which did not express CD14 and CD42a and expressed CD36 at low levels were sorted (CD34 pos CD36 low , population C) (Figure 1(b) ). Approximately 7,500 C cells were recovered from the buffy coat of a blood donation (Table 1) . This low number prevented reanalyses for purity of this cell population and limited its functional characterization. The CD14 neg CD34 neg cells which expressed CD36 at high levels (CD34 neg CD36 high , population D) was not sorted because of its high CD42a expression, which suggest that the may have been represented by megakaryocytic precursors [17] .
The flow-through fraction of the CD36 magnetic beads was further purified by sorting (population E). A total of 10 million CD34 neg CD36 neg cells were recovered from an average AB buffy coat (Table 1) .
Cloning Efficiency of AB Populations Prospectively Isolated on the Basis of CD34/CD36
Profiling. The progenitor cell activity in semisolid assays of population A and E is presented in Table 2 . AB MNC were analyzed in parallel as control. As expected, population A was greatly enriched for colony forming cells (cloning efficiency 16%) and generated both BFU-E-and CFU-GM-derived colonies (in a 1 : 1 ratio). It also contained few (0.001%) CFU-GEMM. By contrast, population E had a cloning efficiency 40% lower than that of MNC and generated mainly (80%) erythroid bursts. No difference in size and morphology was observed among erythroid bursts originated from population A and E and MNC (insert in Table 1 ), an indication that the BFU-E present in the different fractions had similar proliferation/maturation potential.
Expansion Potential under HEMA Conditions of AB Populations Prospectively Isolated on the Basis of CD34/CD36
Profiling. The expansion potential under HEMA conditions of AB populations prospectively isolated on the basis of CD34/ CD36 profiling is compared in Figure 2 (a) and Table 1 . AB MNC were analyzed in parallel as control. As expected, under HEMA conditions, population A had great proliferation potential expressing FIs between 900 (Figure 2(a) ) and 24,000 (average FI = 9, 000, Table 1 ) compared to FI < 10 of the corresponding MNC. Significant numbers of cells were also generated by population B and C which expressed FI of 100 and 60 by day 13 (Figure 2(a) and Table 1 ). By contrast, population E had FI as low as 1-3. However, given the great numbers of cells segregating in this fraction (>10 7 ), population E generated many cells (∼10 7 ) under HEMA conditions (FI ∼ 1).
Maturation Potential of AB MNC Populations Prospectively Isolated on the Basis of CD34/CD36
Profiling. The lineage and maturation stage of the progeny of AB MNC and of AB populations prospectively isolated on the basis of CD36/ CD34 profiling is presented in Figure 2(b) . EBs maturation was defined on the basis of CD36/CD235a profiling which divides EBs into three populations: CD36 pos CD235a neg/low (pro-erythroblasts); CD36 pos /CD235a med/high (basophilic erythroblasts), CD36 low CD235a high (orthochromatic erythroblasts) [5] . A fourth population of CD36 low CD235a low cells with low forward and side scatter is composed by pyrenocytes [20] .
In cultures of MNC, cells with an immature EBs phenotype (CD36 pos CD235a neg ) became detectable very quickly (2% by day 2) while non-EBs became detectable in modest numbers (6-7%) by day 10. Mature EBs (CD36 pos CD235a pos ) were detected by day 6 (15%) and reached a frequency >70% by day 10. By day 15, immature EBs became barely detectable and numerous cells with CD36 low CD235a high phenotype (both larger cells corresponding to orthochromatic EBs, 18%, and smaller cells corresponding to pyrenocytes, 40%) were detected (Figure 2(b) ).
In HEMA cultures of population A, immature EBs were also detected very early (10% by day 2) but the frequency of mature EBs reached 10% only by day 8. By day 15, the cultures contained significant numbers (22%) of CD36 low / CD235a high orthochromatic EBs but no pyrenocytes (Figure 2(b) ).
In HEMA culture of population B, numbers of cells sufficient for antigenic profiling were obtained by day 6. CD36 pos CD235a neg cells represented the majority (∼83%) of the cells from day 6 to day 8. In these cultures, mature CD36 pos CD235a pos EBs were observed at earlier time points with respect to cultures of population A (3% and 10% of CD36 pos CD235a pos cells by day 6-7 versus day 7-8 in cultures of population B and A, resp.) (Figure 2(b) ). By day 15, the maturation phenotype of the progeny of population B and A was the same.
HEMA cultures of population C were originally seeded with number of cells comparable to those used for population A and B (∼7,500 cells with respect to 9,500-10,000 cells used for the two other populations). However, cultures of population C grew very slow (see Figure 2(a) CD235a high stage (7.5% by day 13). Pyrenocytes were detectable in these cultures at levels similar to those observed in cultures of MNC (24%) by day 15.
In conclusion, in spite of differences in kinetics, all the populations analyzed in this study generated EBs under HEMA conditions.
Discussion
CD36/CD34 profiling identifies at least four populations present in AB MNC capable to generate colonies in semisolid assay and EBs under HEMA conditions.
In semisolid assay, only 9% of the original HPCs activity was recovered among the purified fractions (8.1% in population A and 0.8% in population B). Although the cloning efficiency of population B and C is not known, given the low cell content of these populations (∼15,000 cells in total, Table 1 ), they may contain at most 5% of the MNC HPCs activity. Therefore, >80% of the HPCs activity present in the MNC was lost during the purification procedure. This result suggests the hypothesis that some of the HPCs activity of the MNC is due to pre-HPCs cells which became HPCs in neg CD36 neg population is still to be identified, although preliminary results indicate that these cells may express CD44 [22] , the receptor for hyaluronic acid which interacts also with osteopontin and collagen [23] (data not shown).
By contrast with the great loss of colony forming cells observed with the purification of AB MNC (Table 2) , the purification procedures did not lead to great losses of EPC, as indicated by the observation that the sum of the numbers of EBs generated by the four purified fractions is only modestly (7.5 × 10 8 versus 2.7 × 10 9 ) lower than that generated by MNC (Table 1) . Under HEMA conditions, the population which generated the greatest numbers of EBs was population A, only 27% of which had been recovered during the purification procedures (Table 1) . Cultivation under HEMA conditions of a population A containing all the CD34 pos CD36 neg cells present in one donation (100% recovery) would generate as many as 2.3 × 10 9 EBs, a number very similar to that observed in cultures of MNC. These data indicate cell loss during the purification procedure, rather than great EBs generation by CD34 neg HPCs, as the main reason for the overall greater output of EBs from MNC than from CD34 pos cells in HEMA culture. Based on FI and on the time required to mature in culture, the four EPC populations identified in AB were classified according to the hierarchical model presented in Figure 3 . CD34 pos CD36 neg cells may represent earlier cells, probably HPCs (they contain both BFU-E and CFU-GM), while CD34 pos CD36 pos and CD34 neg CD36 pos cells may represents early and late erythroid restricted progenitor cells (EPC), respectively. It is possible that these cell populations are linked in a mother-daughter relationship. It is difficult to classify population E in this model. Since the majority of the cells in this population is likely represented by differentiated precursors, it is conceivable that the progenitor cells represent in this fraction are a rare population with such a great proliferation potential to express FI = 1. This hypothesis is also supported by the observation that population E was the slowest population to generate EBs (CD36 pos CD235a pos cells were not detected before day 6). It is suggested that this population may contain precursor cells which are capable to generate CD34 pos cells. Further studies involving time course analyses of the expression of CD34 among the progeny of CD34 neg CD36 neg E cells are required to clarify this important point. Since the growth factors used to stimulate HEMA culture were selected for optimal EB, and not CD34 cell, generation [15] , it is possible that preculture of CD34 neg CD36 neg E cells under conditions which promote CD34 cell proliferation (using growth factor combinations including FLT3 ligand or thrombopoietic) [24, 25] , will allow generation of greater numbers of EBs when the progeny of their cells will be in turn cultured under HEMA conditions. Also intriguing is the observation that population E is the only purified populations to generate great numbers of pyrenocytes by day 15, an indication that its progeny underwent significant levels of enucleation in HEMA. The presence of macrophages greatly favors the enucleation process [26] . In HEMA culture, macrophages are present as contaminant in cultures of MNC which routinely generate pyrenocytes by day 15 (Figure 1(b) ). These cells were removed by the purification process from all the other populations which did not generate pyrenocytes by day 15 and/or of their precursor cells, in the enucleation of human EBs generated under HEMA conditions. In conclusion, CD34/CD36 profiling identifies a hierarchy of EPC in AB. Although under HEMA conditions the majority of EBs were generated by CD34 pos cells, it is possible that further improvement of the culture system by favoring proliferation of CD34 neg cells, may further increase the number of EBs generated by AB.
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